Breaking News, Promotions & Moves

CPTx Appoints David Maier to Lead gxstrands Business Unit

Maier will build strategic partnerships and expand capacity and service breadth to meet growing demand for custom ssDNA manufacturing solutions.

Author Image

By: Charlie Sternberg

Associate Editor

CPTx, a pioneer in the development and manufacturing of novel genetic medicines built with single-stranded DNA (ssDNA), has appointed David Maier to lead the contract development and manufacturing (CDMO) business unit focused on ssDNA supply called gxstrands. Maier will build strategic partnerships and expand capacity and service breadth to meet growing demand for custom ssDNA manufacturing solutions enabling next-generation genetic medicines. “Over the past decade, our team has developed ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters